Spots Global Cancer Trial Database for blood and marrow transplant (bmt)
Every month we try and update this database with for blood and marrow transplant (bmt) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation | NCT03842696 | Hematologic Dis... Acute Leukemia ... Chronic Myeloge... Chronic Myeloge... Chronic Myeloge... Myelodysplastic... Mantle Cell Lym... Follicular Lymp... Diffuse Large B... Non Hodgkin Lym... Graft Vs Host D... Graft-versus-ho... | Vorinostat Blood and Marro... Tacrolimus (or ... Methotrexate Mycophenolate M... Cyclophosphamid... | 3 Years - 39 Years | University of Michigan Rogel Cancer Center | |
| High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma | NCT00186394 | Lymphoma, Non-H... Blood and Marro... Lymphomas: Non-... | ablative alloge... | 18 Years - 61 Years | Stanford University | |
| 90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL | NCT00186589 | Lymphoma, Non-H... Blood and Marro... | 90Y Ibritumomab... | 18 Years - 70 Years | Stanford University | |
| Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies | NCT00186342 | Acute Disease Myelodysplastic... Leukemia, Myelo... Myeloproliferat... Blood and Marro... Myelodysplastic... Leukemia | ablative alloge... | 51 Years - 60 Years | Stanford University | |
| Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors | NCT00186225 | Blood Cancer Blood and Marro... | ablative alloge... | 4 Weeks - 50 Years | Stanford University | |
| Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies | NCT00186342 | Acute Disease Myelodysplastic... Leukemia, Myelo... Myeloproliferat... Blood and Marro... Myelodysplastic... Leukemia | ablative alloge... | 51 Years - 60 Years | Stanford University | |
| 90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL | NCT00186589 | Lymphoma, Non-H... Blood and Marro... | 90Y Ibritumomab... | 18 Years - 70 Years | Stanford University | |
| Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission | NCT00186381 | Leukemia, Myelo... Leukemia Blood and Marro... | high dose chemo... | 16 Years - 69 Years | Stanford University | |
| Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation | NCT00185757 | Multiple Myelom... Blood and Marro... | Cytokine Induce... | 18 Years - 75 Years | Stanford University | |
| Autologous Stem Cell Rescue for Primary Amyloidosis | NCT00186407 | Amyloidosis Blood and Marro... | high dose chemo... | 18 Years - 75 Years | Stanford University | |
| Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis | NCT01860170 | Hematological M... | Cohort 1-Bortez... Cohort 2-Bortez... Cohort 3-Bortez... | 18 Years - | Spectrum Health Hospitals | |
| Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG | NCT00899847 | Transplantation... Transplantation... Multiple Myelom... Blood and Marro... | Autologous peri... Allogeneic peri... Filgrastim Cyclophosphamid... Melphalan Cyclosporine Total lymphoid ... Rabbit anti-thy... Mycophenolate M... Solumedrol Diphenhydramine Acetaminophen Hydrocortisone | 18 Years - 75 Years | Stanford University | |
| Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission | NCT00186381 | Leukemia, Myelo... Leukemia Blood and Marro... | high dose chemo... | 16 Years - 69 Years | Stanford University | |
| Allo BMT in Advanced Leukemia or High Grade Lymphoma | NCT00186290 | Lymphoma, Non-H... Leukemia Blood and Marro... Lymphomas: Non-... | ablative alloge... | - 50 Years | Stanford University | |
| Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation | NCT03842696 | Hematologic Dis... Acute Leukemia ... Chronic Myeloge... Chronic Myeloge... Chronic Myeloge... Myelodysplastic... Mantle Cell Lym... Follicular Lymp... Diffuse Large B... Non Hodgkin Lym... Graft Vs Host D... Graft-versus-ho... | Vorinostat Blood and Marro... Tacrolimus (or ... Methotrexate Mycophenolate M... Cyclophosphamid... | 3 Years - 39 Years | University of Michigan Rogel Cancer Center | |
| Allo BMT in Advanced Leukemia or High Grade Lymphoma | NCT00186290 | Lymphoma, Non-H... Leukemia Blood and Marro... Lymphomas: Non-... | ablative alloge... | - 50 Years | Stanford University | |
| Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders | NCT00186576 | Myelodysplastic... Myeloproliferat... Blood and Marro... Myelodysplastic... Myeloproliferat... | nonmyeloablativ... | 18 Years - 75 Years | Stanford University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
